NO933393D0 - Kinolonkarboksylsyrer - Google Patents

Kinolonkarboksylsyrer

Info

Publication number
NO933393D0
NO933393D0 NO933393A NO933393A NO933393D0 NO 933393 D0 NO933393 D0 NO 933393D0 NO 933393 A NO933393 A NO 933393A NO 933393 A NO933393 A NO 933393A NO 933393 D0 NO933393 D0 NO 933393D0
Authority
NO
Norway
Prior art keywords
quinolonecarboxylic
Prior art date
Application number
NO933393A
Other languages
English (en)
Other versions
NO933393L (no
Inventor
Uwe Petersen
Wilfried Schroeck
Dieter Haebisch
Andreas Krebs
Thomas Schenke
Thomas Philipps
Klaus Grohe
Rainer Endermann
Klaus-Dieter Bremm
Karl-Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO933393D0 publication Critical patent/NO933393D0/no
Publication of NO933393L publication Critical patent/NO933393L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO933393A 1992-10-09 1993-09-23 Kinolonkarboksylsyrer NO933393L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4234078A DE4234078A1 (de) 1992-10-09 1992-10-09 Chinoloncarbonsäuren

Publications (2)

Publication Number Publication Date
NO933393D0 true NO933393D0 (no) 1993-09-23
NO933393L NO933393L (no) 1994-04-11

Family

ID=6470084

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933393A NO933393L (no) 1992-10-09 1993-09-23 Kinolonkarboksylsyrer

Country Status (19)

Country Link
US (1) US5480879A (no)
EP (1) EP0591808A1 (no)
JP (1) JPH0820587A (no)
KR (1) KR940009193A (no)
CN (1) CN1090285A (no)
AU (1) AU666772B2 (no)
CA (1) CA2107812A1 (no)
CZ (1) CZ9302001A3 (no)
DE (1) DE4234078A1 (no)
FI (1) FI934411L (no)
HU (1) HUT66376A (no)
IL (1) IL107188A0 (no)
MX (1) MX9306023A (no)
NO (1) NO933393L (no)
NZ (1) NZ248871A (no)
PL (1) PL300628A1 (no)
SK (1) SK109293A3 (no)
TW (1) TW288018B (no)
ZA (1) ZA937474B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023153A1 (en) * 1994-02-25 1995-08-31 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
HUP9602872A3 (en) * 1995-02-17 1999-03-01 Daiichi Asubio Pharma Co Ltd Penem derivatives and antimicrobial agent containing the same
DE19546249A1 (de) 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP1015445B1 (en) * 1997-09-15 2009-02-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
DE19927412A1 (de) * 1999-06-16 2000-12-21 Bayer Ag Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0]nonan
DE19931115A1 (de) * 1999-07-06 2001-01-11 Bayer Ag Racemisierung von R, S-Dioxo-Benzylpyrrolopiperidin
AU2001261748A1 (en) * 2000-05-19 2001-12-03 Alcon Laboratories Inc. Antibiotic compositions for treatment of the eye, ear and nose
JP2008502734A (ja) * 2004-06-10 2008-01-31 フオブ・シンセシス・インコーポレーテツド グラム陽性カルバペネム抗菌物質及びその調製方法
CN1325494C (zh) * 2005-08-18 2007-07-11 中国药科大学 3-位取代的萘啶酮类化合物及其制备方法和在制药中的应用
DK2001862T3 (da) 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
BRPI0709220A2 (pt) 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
US7692015B2 (en) * 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (it) 2009-03-06 2012-04-20 Italiana Sint Spa Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
EP2590978B1 (en) 2010-06-18 2017-09-20 FOB Synthesis, Inc. Carbapenem antibacterials with gram-negative activity
CN102952130B (zh) * 2011-08-24 2016-03-23 重庆华邦胜凯制药有限公司 手性合成(s,s)-2,8-二氮杂双环壬烷的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JPH03188080A (ja) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
EP0492277A3 (en) * 1990-12-20 1992-10-14 F. Hoffmann-La Roche Ag Cephalosporin derivatives

Also Published As

Publication number Publication date
HU9302843D0 (en) 1993-12-28
CZ9302001A3 (en) 1994-04-13
CA2107812A1 (en) 1994-04-10
AU666772B2 (en) 1996-02-22
JPH0820587A (ja) 1996-01-23
CN1090285A (zh) 1994-08-03
FI934411A0 (fi) 1993-10-07
SK109293A3 (en) 1994-09-07
NO933393L (no) 1994-04-11
EP0591808A1 (de) 1994-04-13
KR940009193A (ko) 1994-05-20
MX9306023A (es) 1994-05-31
DE4234078A1 (de) 1994-04-14
PL300628A1 (en) 1994-05-16
NZ248871A (en) 1995-12-21
ZA937474B (en) 1994-04-26
HUT66376A (en) 1994-11-28
US5480879A (en) 1996-01-02
TW288018B (no) 1996-10-11
FI934411A7 (fi) 1994-04-10
AU4864493A (en) 1994-04-21
FI934411L (fi) 1994-04-10
IL107188A0 (en) 1994-01-25

Similar Documents

Publication Publication Date Title
NO933393D0 (no) Kinolonkarboksylsyrer
DE59302851D1 (de) Sportschuh
BR9305745A (pt) Quebra-luz
DE59301902D1 (de) Kassenlade
ATA236892A (de) Rotornut
FI935044L (fi) Foerbaettrad vaexelskena avsedd foer vaexelanordningar
ATA227792A (de) Sportschuh
BR9301712A (pt) Aplainador
DE59301762D1 (de) Chlorethylsulfonylbenzaldehyde
PT8484T (pt) Sacarrolhas aperfeicoado
DE59206388D1 (de) Kabeleckkanal
ATA25994A (de) Alpinski
ATA58493A (de) Lochstein
BR9200611A (pt) Hidrocofre
BR9200554A (pt) Lixoduto
BR9200298A (pt) Microsisten-telesupervisao
BR9200296A (pt) Varre-lava
BR9200295A (pt) Aurissima
BR9200231A (pt) Agrupador
BR7202026U (pt) Aero-mala
BR7201859U (pt) Cambao
BR7201352U (pt) Luninaria
BR7200879U (pt) Cocho saleiro biazi
BR7200318U (pt) Cabide sanfonado
BR7200240U (pt) Vari-watt